Westerman, Ronny (2014):

Die Überlebenszeitanalyse von fertilen und subfertilen Männern. Eine Bewertung der Heterogenitätsintensitäten mit Hilfe von parametrischen Frailty-Modellen.

Saarbrücken: Südwestdeutscher Verlag für Hochschulschriften.

GBD 2021 Fertility and Forecastin Collaborators (2024):

Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021.

The Lancet.

Prendes, C.F.; Rantner, B.; Hamwi, T.; Stana J.; Feigin, V.L.; Stavroulakis, K.; Tsilimparis, N.; GBD Collaborators Study Group (2024):

Burden of stroke in Europe: An analysis of the Global Burden of Disease Study findings from 2010 to 2019.

Stroke 55(2): 432–442.

GBD 2021 Nervous System Disorders Collaborators (2024):

Global, regional, and national burden of disorders affecting the nervous system, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.

The Lancet Neurology 23(4): 344–381.

GBD 2021 Demographics Collaborators (2024):

Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021.

The Lancet .

GBD 2019 IMID Collaborators (2023):

Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the Global Burden of Disease Study 2019.

EClinicalMedicine 9:64:102193.

GBD 2019 Peripheral Artery Disease Collaborators (2023):

Global burden of peripheral artery disease and its risk factors, 1990-2019: A Systematic Analysis for the Global Burden of Disease Study 2019.

Lancet Glob Health e1553-e1565 .

GBD 2019 Lip, Oral, and Pharyngeal Cancer Collaborators (2023):

The Global, Regional, and National Burden of Adult Lip, Oral, and Pharyngeal Cancer in 204 Countries and Territories. A Systematic Analysis for the Global Burden of Disease Study 2019.

JAMA Oncology .

GBD 2019 Europe Hepatitis B & C Collaborators (2023):

Hepatitis B and C in Europe: an update from the Global Burden of Disease Study 2019.

The Lancet Public Health 8(9): e701–e716.

GBD 2019 Child and Adolescent Communicable Disease Collaborators (2023):

The unfinished agenda of communicable diseases among children and adolescents before the COVID-19 pandemic, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019.

The Lancet 29.

Shin YH, Hwang J, Kwon R, Lee SW, Kim MS; GBD 2019 Allergic Disorders Collaborators; Shin JI, Yon DK (2023):

Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: A systematic analysis for the Global Burden of Disease Study 2019.

Allergy.

GBD 2021 Diabetes Collaborators (2023):

Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021.

The Lancet .

GBD 2019 Chronic Respiratory Diseases Collaborators (2023):

Global burden of chronic respiratory diseases and risk factors, 1990-2019: an update from the Global Burden of Disease Study 2019.

EClinicalMedicine 59:101936.

GBD 2019 Cancer Risk Factors Collaborators (2022):

The global burden of cancer attributable to risk factors, 2010-19: a systematic analysis for the Global Burden of Disease Study 2019.

The Lancet 400(10352): 563–591.

GBD 2020 Alcohol Collaborators (2022):

Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020.

The Lancet 400(10347): 185–235.

Kuss, Oliver; Becher, Heiko; Wienke, Andreas et al. (2022):

Statistical Analysis in the German National Cohort (NAKO) – Specific Aspects and General Recommendations.

European Journal of Epidemiology 37. : Springer: 429–436.

GBD 2019 Colorectal Cancer Collaborators (2022):

Global, regional, and national burden of colorectal cancer and its risk factors, 1990–2019. A systematic analysis for the Global Burden of Disease Study 2019.

The Lancet Gastroenterology & Hepatology 7(7).

Armocida; Benedetta et al. (2022):

Burden of non-communicable diseases among adolescents aged 10-24 years in the EU, 1990-2019: a systematic analysis of the Global Burden of Diseases Study 2019.

Lancet Child and Adolescent Health 6(6): 367–383.

GBD 2019 Ageing Collaborators (2022):

Global, regional, and national burden of diseases and injuries for adults 70 years and older: systematic analysis for the Global Burden of Disease 2019 Studys.

BMJ 376.

Jakovljevic, Mihajlo; Lamnisos, Demetrios; Westerman, Ronny; Chattu, Vijay Kumar; Cerda, Arcadio (2022):

Future health spending forecast in leading emerging BRICS markets in 2030: health policy implications.

Health Research Policy and Systems 20(23).

GBD 2019 Adolescent Young Adult Cancer Collaborators (2022):

The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019.

The Lancet Oncology 23(1): 27–52.

Global Burden of Disease 2019 Cancer Collaborators (2022):

Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019. A Systematic Analysis for the Global Burden of Disease Study 2019.

JAMA Oncology 1;8(3): 420–444.

Local Burden of Diseas Vaccine Coverage Collaborators (2021):

Mapping routine measles vaccination in low- and middle-income countries.

Nature 589: 415–419.

GBD 2019 HIV Collaborators (2021):

Global, regional, and national sex-specific burden and control of the HIV epidemic, 1990-2019, for 204 countries and territories: the Global Burden of Diseases Study 2019.

The Lancet HIV 8(10): e663–e651.

Westerman, Ronny; Kuhnt, Anne-Kristin (2022):

Metabolic risk factors and fertility disorders: A narrative review of the female perspective.

Reproductive Biomedicine & Society Online: 66–74.

GBD 2019 Under-5Mortality Collaborators (2021):

Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019.

The Lancet 398(10303): 870–905.

GBD 2019 Dementia Collaborators (2021):

Use of multidimensional item response theory methods for dementia prevalence prediction: an example using the Health and Retirement Survey and the Aging, Demographics, and Memory Study.

The BMC Medical Informatics and Decision Making 21(1):241.

Local Burden of Disease HIV Collaborators (2020):

Mapping subnational HIV mortality in six Latin American countries with incomplete vital registration systems.

BMC Medicine 19, 4.

Roth, Gregory A. et al. (2020):

Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019. Update From the GBD 2019 Study.

Journal of the American College of Cardiology 76 (25): 2982–3021.

Krstic, Kristijan; Westerman, Ronny; Kumar Chattu, Vijay; Ekkert, Natalia V.; Jakovljevic, Mihajlo (2020):

Corona-Triggered Global Macroeconomic Crisis of the Early 2020s.

International Journal of Environmental Research and Public Health 17 (24), 9404.

GBD 2019 Viewpoint Collaborators (2020):

Five insights from the Global Burden of Disease Study 2019.

The Lancet 396(10258): 1135–1159.

GBD 2019 Diseases and Injuries Collaborators (2020):

Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019. A systematic analysis for the Global Burden of Disease Study 2019.

The Lancet 396(10258): 1204–1222.

GBD 2019 Risk Factors Collaborators (2020):

Global Burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.

The Lancet 396(10258): 1223–1249.

GBD 2019 Universal Health Coverage Collaborators (2020):

Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990-2019. A systematic analysis for the Global Burden of Disease Study 2019.

The Lancet 396(10258): 1250–1284.

GBD 2019 Demographics Collaborators (2020):

Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950-2019. A comprehensive demographic analysis for the Global Burden of Disease Study 2019.

The Lancet 396(10258): 1160–1203.

Local Burden of Disease WaSH Collaborators (2020):

Mapping geographical inequalities in access to drinking water and sanitation facilities in low-income and middle-income countries, 2000-17.

Lancet Glob Health 8(9): e1162–e1185.

Local Burden of Diseas Diarrhoea Collaborators (2020):

Mapping geographical inequalities in oral rehydration therapy coverage in low-income and middle-income countries, 2000-17.

Lancet Glob Health 8(8): e1038–e1060.

Local Burden of Diseas Diarrhoea Collaborators (2020):

Mapping geographical inequalities in childhood diarrhoeal morbidity and mortality in low-income and middle-income countries, 2000-17. Analysis for the Global Burden of Disease Study 2017.

The Lancet 395(10239): 1779–1801.

GBD Chronic Respiratory Disease Collaborators (2020):

Prevalence and attributable health burden of chronic respiratory diseases, 1990-2017. A systematic analysis for the Global Burden of Disease Study 2017.

The Lancet Respiratory Medicine 8(6): 585–596.

Westerman, Ronny (2020):

Biomarkers for demographic research: sperm counts and other male infertility biomarkers.

Biodemography and Social Biology 65(1): 73–87.

GBD 2017 Cirrhosis Collaborators (2020):

The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017. A systematic analysis for the Global Burden of Disease Study 2017.

The Lancet Gastroenterol & Hepatol (3): 245–266.

GBD 2017 Stomach Cancer Collaborators (2020):

The global, regional, and national burden of stomach cancer in 195 countries, 1990-2017. A systematic analysis for the Global Burden of Disease Study 2017.

The Lancet Gastroenterol & Hepatol 5(1): 42–54.

GBD 2017 Colorectal Cancer Collaborators (2019):

The global, regional, and national burden of colorectal cancer and its attributable risk factors in 195 countries and territories, 1990-2017. A systematic analysis for the Global Burden of Disease Study 2017.

The Lancet Gastroenterol Hepatol 4(12): 913–933.

GBD 2017 Pancreatic Cancer Collaborators (2019):

The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990-2017. A systematic analysis for the Global Burden of Disease Study 2017.

The Lancet Gastroenterol Hepatol 4(12): 934–947.

GBD 2017 Stomach Cancer Collaborators (2019):

The global, regional, and national burden of stomach cancer in 195 countries, 1990-2017. A systematic analysis for the Global Burden of Disease Study 2017.

The Lancet Gastroenterol Hepatol 5(1): 42–45.

Burstein, Roy et al. (2019):

Mapping 123 million neonatal, infant and child deaths between 2000 and 2017.

Nature 574: 353–358.

Westerman, Ronny; Mühlichen, Michael (2019):

Avoidable Cancer Mortality in Germany Since Reunification: Regional Variation and Sex Differences.

Frontiers in Public Health 7(187): 1–11.

GBD 2016 Epilepsy Collaborators (2019):

Global, regional, and national burden of epilepsy, 1990-2016. A systematic analysis for the Global Burden of Disease Study 2016.

The Lancet Neurology 18(4): 357–375.

GBD 2016 Dementia Collaborators (2019):

Global, regional, and national burden of Alzheimer's disease and other dementias, 1990-2016. A systematic analysis for the Global Burden of Disease Study 2016.

The Lancet Neurology 18(1): 88–106.

GBD 2016 Stroke Collaborators (2019):

Global, regional, and national burden of stroke, 1990-2016. A systematic analysis for the Global Burden of Disease Study 2016.

The Lancet Neurology 18(5): 439–458.

Mohsen Naghavi, on behalf of the Global Burden of Disease Self-Harm Collaborators (2019):

Global, regional, and national burden of suicide mortality 1990 to 2016. A systematic analysis for the Global Burden of Disease Study 2016.

The BMJ: 364.

GBD 2017 SDG Collaborators (2018):

Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories. A systematic analysis for the Global Burden of Disease Study 2017.

The Lancet 392: 2091–2138.

GBD 2016 Parkinson's Disease Collaborators (2018):

Global, regional, and national burden of Parkinsons disease, 1990-2016. A systematic analysis for the Global Burden of Disease Study 2016.

The Lancet Neurol. 11: 939–953.

GBD 2017 Population and Fertility Collaborators (2018):

Population and fertility by age and sex for 195 countries and territories, 1950–2017. A systematic analysis for the Global Burden of Disease Study 2017.

The Lancet 392(10159): 1995–2051.

GBD 2017 Mortality Collaborators (2018):

Global, regional, and national age-sex-specific mortality and life expectancy, 1950-2017. A systematic analysis for the Global Burden of Disease Study 2017.

The Lancet 392: 1684–1735.

GBD 2017 Cause of Death Collaborators (2018):

Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017. A systematic analysis for the Global Burden of Disease Study 2017.

The Lancet 392: 1736–1788.

GBD 2017 Risk Factor Collaborators (2018):

Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017. A systematic analysis for the Global Burden of Disease Study 2017.

The Lancet 392: 1923–1994.

GBD 2017 DALYs and HALE Collaborators (2018):

Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017. A systematic analysis for the Global Burden of Disease Study 2017.

The Lancet 392(10159): 1859–1922.

GBD 2016 Alcohol Collaborators (2018):

Alcohol use and burden for 195 countries and territories, 1990-2016. A systematic analysis for the Global Burden of Disease Study 2016.

The Lancet 392(10152): 1015–1035.

GBD 2016 Headache Collaborators (2018):

Global, regional, and national burden of migraine and tension-type headache, 1990-2016. A systematic analysis for the Global Burden of Disease Study 2016.

The Lancet Neurol. 11: 954–976.

GBD 2016 Healthcare Access and Quality Collaborators (2018):

Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations. A systematic analysis from the Global Burden of Disease Study 2016.

The Lancet 391(10136): 2236–2271.

Peters, Frederik; Westphal, Christina; Kramer, Anneke; Westerman, Ronny (2018):

Is the Rise in the Prevalence of Renal Replacement Therapy at Older Ages the Price for Living Longer?

Frontiers in Public Health 6: 138.

GBD 2015 Eastern Mediterranean Region Mental Health Collaborators (2018):

The burden of mental disorders in the Eastern Mediterranean region, 1990–2015. Findings from the global burden of disease 2015 study.

International Journal of Public Health 63(Suppl 1): S25–S37.

GBD 2015 Eastern Mediterranean Region Maternal Mortality Collaborators (2018):

Maternal mortality and morbidity burden in the Eastern Mediterranean Region. Findings from the Global Burden of Disease 2015 study.

International Journal of Public Health 63(Suppl 1): S47–S61.

GBD Tuberculosis Collaborators (2018):

The global burden of tuberculosis. Results from the Global Burden of Disease Study 2015.

The Lancet Infectious Diseases 18(3): 261–284.

GBD 2015 Healthcare Access and Quality Collaborators (2017):

Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990–2015. A novel analysis from the Global Burden of Disease Study 2015.

The Lancet 390(10091): 231–266.

Roth, Gregory A. et al. (2017):

Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015.

Journal of the American College of Cardiology 70(1): 1–25.

The GBD 2015 Obesity Collaborators (2017):

Health Effects of Overweight and Obesity in 195 Countries over 25 Years.

The New England Journal of Medicine 377(1): 13–27.

The Global Burden of Disease Child and Adolescent Health Collaboration (2017):

Child and Adolescent Health From 1990 to 2015. Findings From the Global Burden of Diseases, Injuries, and Risk Factors 2015 Study.

JAMA Pediatrics 171(6): 573–592.

Fitzmaurice, C. et al. (2017):

Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015. A Systematic Analysis for the Global Burden of Disease Study.

JAMA Oncology 3(4): 524–548.

Moradi-Lakeh, Maziar et al. (2017):

Burden of musculoskeletal disorders in the Eastern Mediterranean Region, 1990–2013. Findings from the Global Burden of Disease Study 2013.

Annals of the Rheumatic Diseases 76(8): 1365–1373.

Charara, Raghid et al. (2017):

The Burden of Mental Disorders in the Eastern Mediterranean Region, 1990–2013.

PLoS One 12(1): e0169575.

Forouzanfar, Mohammad H. et al. (2017):

Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990–2015.

JAMA 317(2): 165–182.

Khalil, Ibrahim et al. (2016):

Burden of Diarrhea in the Eastern Mediterranean Region, 1990-2013. Findings from the Global Burden of Disease Study 2013.

The American Society of Tropical Medicine and Hygiene 95(6): 1319–1329.

Global Burden of Disease Cancer Collaboration (2016):

Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015. A Systematic Analysis for the Global Burden of Disease Study.

JAMA Oncology 3(4): 524–548.

GBD 2015 Disease and Injury Incidence and Prevalence Collaborators (2016):

Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015. A systematic analysis for the Global Burden of Disease Study 2015.

The Lancet 388(10053): 1545–1602.

GBD 2015 Risk Factors Collaborators (2016):

Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015. A systematic analysis for the Global Burden of Disease Study 2015.

The Lancet 388(10053): 1659–1724.

GBD 2015 Child Mortality Collaborators (2016):

Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980–2015. A systematic analysis for the Global Burden of Disease Study 2015.

The Lancet 388(10053): 1725–1774.

GBD 2015 Maternal Mortality Collaborators (2016):

Global, regional, and national levels of maternal mortality, 1990–2015. A systematic analysis for the Global Burden of Disease Study 2015.

The Lancet 388(10053): 1775–1812.

GBD 2015 DALYs and HALE Collaborators (2016):

Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015. A systematic analysis for the Global Burden of Disease Study 2015.

The Lancet 388(10053): 1603–1658.

GBD 2015 SDG Collaborators (2016):

Measuring the health-related Sustainable Development Goals in 188 countries. A baseline analysis from the Global Burden of Disease Study 2015.

The Lancet 388(10053): 1813–1850.

GBD 2015 Mortality and Causes of Death Collaborators (2016):

Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015. A systematic analysis for the Global Burden of Disease Study 2015.

The Lancet 388(10053): 1459–1544.

Mazur, Allan; Westerman, Ronny (2016):

Changing testosterone had no direct effect on HbA1c or weight in diabetic men when TRT was interrupted and then resumed.

Clinical Endocrinology 85(3): 499–500.

Mokdad, Ali H. et al. (2016):

Health in times of uncertainty in the eastern Mediterranean region, 1990–2013. A systematic analysis for the Global Burden of Disease Study 2013.

The Lancet Global Health 4(10): e704–e713.

GBD 2015 HIV Collaborators (2016):

Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2015. The Global Burden of Disease Study 2015.

The Lancet HIV 3(8): e361–e387.

GBD 2013 Risk Factors Collaborators (2015):

Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013. A systematic analysis for the Global Burden of Disease Study 2013.

The Lancet 386(10010): 2287–2323.

Rominger, Marga B. et al. (2015):

Microcalcification-Associated Breast Cancer. Presentation, Successful First Excision, Long-Term Recurrence and Survival Rate.

Breast Care 10(6): 380–385.

GBD 2013 DALYs and HALE Collaborators (2015):

Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013. Quantifying the epidemiological transition.

The Lancet 386(10009): 2145–2191.

Krishnamurthi, R.V. et al. (2015):

Stroke Prevalence, Mortality and Disability-Adjusted Life Years in Children and Youth Aged 0-19 Years. Data from the Global and Regional Burden of Stroke 2013.

Neuroepidemiology 45(3): 177–189.

Krishnamurthi, R.V. et al. (2015):

Stroke Prevalence, Mortality and Disability-Adjusted Life Years in Adults Aged 20-64 Years in 1990-2013. Data from the Global Burden of Disease 2013 Study.

Neuroepidemiology 45(3): 190–202.

Barker-Collo, S. et al. (2015):

Sex Differences in Stroke Incidence, Prevalence, Mortality and Disability-Adjusted Life Years. Results from the Global Burden of Disease Study 2013.

Neuroepidemiology 45(3): 203–214.

Feigin, Valery L. et al. (2015):

Atlas of the Global Burden of Stroke (1990-2013). The GBD 2013 Study.

Neuroepidemiology 45(3): 230–236.

Feigin, Valery L. et al. (2015):

Update on the Global Burden of Ischemic and Hemorrhagic Stroke in 1990-2013. The GBD 2013 Study.

Neuroepidemiology 45(3): 161–176.

Global Burden of Disease Study 2013 Collaborators (2015):

Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013. A systematic analysis for the Global Burden of Disease Study 2013 .

The Lancet 386(9995): 743–800.

Global Burden of Disease Cancer Collaboration (2015):

The Global Burden of Cancer 2013.

JAMA Oncology 1(4): 505–527.

Global Burden of Disease 2013 Mortality and Causes of Death Collaborators (2015):

Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013. A systematic analysis for the Global Burden of Disease Study 2013.

The Lancet 385(9963): 117–171.

Westerman, Ronny et al. (2015):

How does sperm count predicts differential in survival for an Andrologic Clinical Cohort?

Das Gesundheitswesen 77(08/09): A399.

Mazur, A.; Westerman, R.; Werdecker, A.; Mueller, U. (2014):

Testosterone and type 2 diabetes in men.

Aging Male 17(1): 18–24.

Murray, C.J. et al. (2014):

Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013. A systematic analysis for the Global Burden of Disease Study 2013.

The Lancet 384(9947): 1005–1070.

Kassebaum, N.J. et al. (2014):

Global, regional, and national levels and causes of maternal mortality during 1990-2013. A systematic analysis for the Global Burden of Disease Study 2013.

The Lancet 384(9947): 980–1004.

Wang, H. et al. (2014):

Global, regional, and national levels of neonatal, infant, and under-5 mortality during 1990-2013. A systematic analysis for the Global Burden of Disease Study 2013.

The Lancet 384 (9947): 957–979.

Mazur, Allan; Westerman, Ronny; Mueller, Ulrich (2013):

Is rising obesity causing a secular (age-independent) decline in testosterone among American men?

PLoS ONE 8(10): e76178.

Jakovljevic, Mihajlo; Westerman, Ronny; Sharma, Tarang; Lamnisos, Demetris (2020):

Aging and Global Health Section, Principles, and Drivers of Global Health.

Haring, Robin; Kickbusch, Ilona; Ganten, Detlev; Moeti, Matshidiso (Eds.) Handbook of Global Health. Cham: Springer: 1–30.

Westerman, Ronny (2022):

NAKO Gesundheitsstudie: Eine erste Bilanz. Eine Langzeituntersuchung mit großem Ziel.

Bevölkerungsforschung Aktuell 4/2022: 3–7.

Mueller, Ulrich; Werdecker, Andrea; Westerman, Ronny; Hoffmann, Wolfgang (2015):

Mortalitäts-Follow-Up der Nationalen Kohorte. Ein neues Projekt am Bundesinstitut für Bevölkerungsforschung.

Bevölkerungsforschung Aktuell 6/2015: 2–9.

Westerman, R.; Mazur, A.; Mueller, U. O. (2014):

Military Career Outcome and Lifespan of Six Classes of Annapolis and West Point Graduates: Causation and Selection Effects.

International Journal of Epidemiology Abstract, 20th IEA World Congress of Epidemiology . Anchorage, AK, USA .

Westerman, R.; Reese, J. P.; Mueller, U. O. (2013):

Copulas and Competing Risks: Applications for Mixture Long-term Survival Models .

JSM Proceedings, Biometric Sections, Alexandria, VA: American Statistical Association: 1140–1148.

Westerman, R. (2012):

Long-Term Survival for Competing Risk Data with Masked Causes .

JSM Proceedings, Biometric Sections, Alexandria, VA: American Statistical Association : 232–238.

Bundesinstitut für Bevölkerungsforschung (2021):

Globale Bevölkerungsentwicklung. Fakten und Trends.

BiB.Bevölkerungs.Studien 1/2021. Wiesbaden: Bundesinstitut für Bevölkerungsforschung.

Seidler, Andreas; Schubert, Melanie; Technische Universität Dresden, Petereit-Haack, Gabriela; Horn, Annett; Kämpf, Daniel; Westerman, Ronny (Ed.) (2020):

Soziale Isolation als Sterblichkeitsrisiko für ältere Menschen.

Kompetenznetz Public Health COVID-19.